New pill could boost exercise for teens with half a heart
Disease control
Recruiting now
This study tests whether a daily pill called udenafil can improve exercise ability in teenagers who had the Fontan procedure for single-ventricle heart disease. About 436 teens aged 12 to 18 will take either the drug or a placebo for 26 weeks. The main goal is to see if their pea…
Phase: PHASE3 • Sponsor: Mezzion Pharma Co. Ltd • Aim: Disease control
Last updated May 11, 2026 20:46 UTC